HopeStage
Back to overview

Anxiety studies

Topics
More filters

Anxiety

Anxiety conditions involve intense, persistent fears or worries that can interfere with everyday life.

5111studies shown
Showing 841-852 of 5,111
Drug study icon
Not recruitingISRCTN03554974

Agomelatine for anxiety

This study isn't currently recruiting.

In Argentina
AnxietyResearch studyAges 18+
Countries
Argentina, Czechia, Finland, + 4 others
Sponsor
Institut de Recherches Internationales Servier (France)
Drug study icon
Active Not RecruitingNCT06741228

Study of DT120 for Generalized Anxiety Disorder (Voyage)

What is this study about?

Researchers are comparing DT120 and placebo to find out how the approaches affect anxiety symptoms in adults with an anxiety condition.

This study is no longer accepting new participants.

Multiple locations, including Gilbert
AnxietyMedication studyAges 18–74
Countries
United States
Sponsor
Definium Therapeutics US, Inc.
Drug study icon
Active Not RecruitingNCT06809595

Study of MM120 for Generalized Anxiety Disorder (Panorama)

What is this study about?

Researchers are comparing DT120, placebo and a simulated comparison procedure to find out how the approaches affect anxiety symptoms in adults with an anxiety condition.

This study is no longer accepting new participants.

Multiple locations, including Little Rock
AnxietyMedication studyAges 18–74
Countries
United States, France, United Kingdom, + 3 others
Sponsor
Definium Therapeutics US, Inc.
Drug study icon
CompletedNCT06805565

ONO-1110 in people with Social Anxiety Disorder

What is this study about?

This study evaluated the safety and effectiveness of ONO-1110 for people with anxiety.

This study has finished and is no longer accepting participants.

Multiple locations, including Fukuoka
AnxietyMedication studyAges 18–65
Countries
Japan
Sponsor
Ono Pharmaceutical Co., Ltd.
Drug study icon
CompletedNCT07193563

ENX-102 for anxiety

What is this study about?

Researchers compared ENX-102 and placebo, tracking side effects to assess safety in people with an anxiety condition.

This study has finished and is no longer accepting participants.

Multiple locations, including Phoenix
AnxietyMedication studyAges 18–70
Countries
United States
Sponsor
Engrail Therapeutics INC

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.